Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

All articles

From buzzword to business lever: How business leaders use AI in practice, for themselves and their company

A practical guide for leaders who want to make good use of AI for personal productivity and corporate impact.

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Article

DNA-Encoded Libraries and AI for Compound Identification

An expert interview on the use of DNA-encoded libraries for connection detection.

Article

Putting AI predictions into practice

An expert interview on the topic of AI-supported predictions.

Article

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.